- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Childhood Sexual Abuse Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Restructuring and Business Bankruptcy
- Wealth Planning, Administration, and Disputes
- Litigation Support Services
-
February 14, 2020Robins Kaplan Recognized in 2020 World Trademark Review 1000
-
February 13, 2020Settlement Announced in Tribal Voting Identification and Ballot Access Case
-
February 7, 2020Los Angeles Attorneys Named to 2020 “Southern California Super Lawyers” List
-
February 21, 2020The Black BigLaw Pipeline Networking Reception
-
February 22, 2020Sanneh Foundation Gala for Goals
-
March 2, 2020Conference of Tribal Lending Commissioners
-
February 11, 2020INSIGHT: California’s Rebuke of Forced Arbitration in Limbo, Full of Uncertainty
-
February 7, 2020Colossus and Xactimate: A Tale of Two AI Insurance Software Programs
-
February 2020Have You Seen My Genes? Preconception Carrier Screening
The America Invents Act:
Changes in the Patent Laws of Special Interest to the Life Sciences Industry
November 4, 2011
After several years of unsuccessful attempts, Congress recently passed the Leahy-Smith America Invents Act (the ‘‘AIA’’),1 containing the most significant changes to the Patent Act in more than 60 years. President Obama signed the AIA into law on Sept. 16.2 This article presents an overview of the major provisions that are significant for practitioners in the life sciences.3
1 H.R. 1249 (112th Congress).
2 Pub. L. No. 112-29.
3 The authors recognize that there is no monolithic ‘‘life sciences industry’’ that speaks with one voice on all issues, but instead use this term to address views that may be common or shared among individuals and entities advancing or using technologies in the biomedical or biotechnological sciences.
The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.